Skip to content
healthcare.dev

Lenalidomide

NDC 69097-604, Lenalidomide, capsule, from Cipla USA Inc..

Product NDC
69097-604
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214618
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-604 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LENALIDOMIDE2.5 mg/1

Pharmacologic classes

Thalidomide Analog [EPC]

Package NDCNDC-11Package
69097-604-736909706047328 CAPSULE in 1 BOTTLE (69097-604-73)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/96df285d-dd13-4083-b2c6-e5c799e7587b

Use it

Look up 69097-604 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-604 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-604. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.